Johnson & Johnson to pay $65.5m in baby powder cancer case
A US jury awards $65.5 million to a mother who developed mesothelioma after using Johnson & Johnson's talc-based baby powder. The company plans to appeal.
Category : Search result: pharmaceutical litigation
Bruce Lehrmann's Defamation Case: A Litigation Warning
The failed defamation case brought by Bruce Lehrmann against Channel Ten serves as a stark warning for future litigants. Explore the details and legal consequences.
UK-US agree zero tariff deal on pharmaceuticals
The UK and US have struck a deal to maintain 0% tariffs on medicines for three years, alongside NHS commitments to increase spending on new drugs. Discover the implications for patients and industry.
Misconduct complaint against DC judge dismissed
A senior court official has dismissed a Justice Department misconduct complaint against federal judge Ana Reyes over her handling of a transgender military ban lawsuit. Discover the full story.
Adani ends legal fight against activist Ben Pennings
Environmental campaigner Ben Pennings declares victory as Adani ends its five-year legal pursuit. A landmark case for protest rights and corporate accountability in the UK.
ADHD medication recalled over effectiveness issues
A popular generic ADHD medication is being recalled nationwide after tests showed it may not dissolve properly, failing to deliver the full dose. Patients urged to check their prescriptions.
Daughter loses £1.1m inheritance court battle
A 72-year-old daughter has lost her legal fight after being disinherited from her mother's £1.1million fortune. The court ruled she failed to show sufficient 'love and respect'. Read the full story.
UK Court Revives £36bn Brazil Dam Case Against BHP
British victims triumph as UK High Court allows historic £36 billion lawsuit against BHP over Brazil's catastrophic Mariana dam collapse to proceed, marking one of largest group claims in English legal history.
Top lawyer ousted in client fund misuse scandal
Prominent London solicitor James Donovan dismissed from PCB Litigation after allegedly misusing millions in client funds for luxury private jet travel, extravagant parties, and personal expenses in shocking financial misconduct case.
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
California Sues Exxon Over Climate Deception
California launches unprecedented legal action against ExxonMobil, alleging the oil giant concealed climate risks for over 30 years while publicly sowing doubt about environmental science.
NHS patients denied vital medications in supply crisis
Exclusive investigation reveals how NHS patients across Britain are being denied essential medicines due to catastrophic supply chain failures, with government accused of prioritising pharmaceutical profits over public health.
TotalEnergies guilty of greenwashing in court ruling
French oil giant TotalEnergies has been ruled by a Paris court to have made misleading environmental claims about its natural gas operations, in a major victory for climate campaigners.
OpenAI Sued Over ChatGPT Training Data
Tech giant OpenAI confronts a major copyright lawsuit alleging ChatGPT was illegally trained on protected material, raising crucial questions about AI development ethics.
Novo Nordisk Board Exodus: Chairman & 6 Directors Depart
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Moderna's Oxfordshire vaccine centre gets green light
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
Trump legal team faces setbacks in Philadelphia court
Donald Trump's attorney Alina Habba and former Florida AG Pam Bondi confronted procedural setbacks during a Philadelphia hearing, raising questions about the former president's legal strategy.
Trump's Ozempic Remark Hits Pharma Stocks
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Trump's Ozempic Price Pledge Shakes Pharma Markets
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
Trump Sues NY Times Over Tax Records Investigation
Former President Donald Trump launches fresh legal action against The New York Times and key journalists, alleging conspiracy in obtaining his tax documents. The high-stakes lawsuit follows previous failed attempts and raises crucial questions about press
Trump Sues New York Times in Defamation Case
Former US President Donald Trump launches legal action against The New York Times, alleging the newspaper published false and defamatory statements about his business practices.
California declares emergency over insulin prices
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Trump's FDA Win: IVF Drug Approved Despite Opposition
In a significant political victory, Donald Trump secures FDA approval for Washington's IVF medication, overcoming fierce opposition and setting new healthcare precedents.
New weight loss jab shows unprecedented 24% reduction
Breakthrough drug Retatrutide demonstrates remarkable 24% weight loss in clinical trials, potentially revolutionising obesity treatment in the UK healthcare landscape.
J&J Pays $700M in Talc Cancer Scandal Settlement
Pharmaceutical giant Johnson & Johnson agrees to pay $700 million settlement amid allegations their talcum powder contained asbestos and caused ovarian cancer in thousands of women.
Johnson & Johnson Faces UK Lawsuit Over Talc Cancer Claims
Global pharmaceutical giant Johnson & Johnson is confronting a major class action lawsuit in the UK, with dozens of women alleging its talc-based products caused their cancers. The legal battle could set a crucial precedent for consumer safety.
Johnson & Johnson £50B talc cancer settlement
Pharmaceutical giant Johnson & Johnson agrees to pay £50 billion to settle claims its talcum powder caused cancer, while continuing to deny product safety concerns.
WHO Alert: Contaminated Cough Syrups Linked to Child Deaths
The World Health Organization issues urgent global warning after contaminated cough syrups are connected to dozens of child fatalities across several nations. Health authorities worldwide are scrambling to remove dangerous medications from circulation.
Page 1 of 4